内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-18 · 构建时间： 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Crinetics Pharmaceuticals, Inc.

CRNX · — · CIK 0001658247 · Healthcare

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

47 同一窗口内观察到的 Form 4 交易行
3 sales · 44 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2023-06-08 · Vivaldi Coelho Rogerio · $110.3K

为什么没有活跃信号？

买入活动无
近期买入无
近期卖出较低
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数？

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。

卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Vivaldi Coelho RogerioDirector
○▼○
Okey StephanieDirector
▼○○
Struthers Richard ScottPresident & CEO
○○○
Fust Matthew KDirector
○○
Deardorf CarenDirector
○○
Nichols WestonDirector
○○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 5 additional owner(s) remain in Form 4 申报证据.

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后，这些模块才会启用。

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-06-08 · Vivaldi Coelho Rogerio.

近期 Form 4 活动

0买入
18卖出
58其他 Form 4 交易行
40SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出3 sale line(s) · 仅供背景
其他44 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

该股票尚未获取市场背景。每日任务会轮转处理美国股票池。

空头余额

FINRA 报告中没有该股票代码的空头余额。

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2023-06-08Vivaldi Coelho Rogerio买入 (P)Common Stock5,000USD 22.06USD 110,300SEC 申报 ↗
2022-04-18EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD买入 (P)Common Stock157,515USD 22.22USD 3,499,983SEC 申报 ↗
2021-10-25EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD买入 (P)Common Stock1,200,000USD 19.80USD 23,760,000SEC 申报 ↗
2021-04-08EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD买入 (P)Common Stock304,136USD 16.44USD 4,999,996SEC 申报 ↗
2020-12-03Struthers Richard Scott买入 (P)Common stock4,000USD 13.10USD 52,400SEC 申报 ↗
2020-12-02Struthers Richard Scott买入 (P)Common stock1,000USD 12.60USD 12,600SEC 申报 ↗
2020-04-17EDELMAN JOSEPH; PERCEPTIVE ADVISORS LLC; PERCEPTIVE LIFE SCIENCES MASTER FUND LTD买入 (P)Common Stock1,071,428USD 14.00USD 14,999,992SEC 申报 ↗

Form 4 申报证据

76 transaction lines in the latest 365-day window; 372 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-01WIERENGA WENDELLD (D)Common Stock122,071USD 85.00USD 10,376,035SEC 申报 ↗
2026-09-01Vivaldi Coelho RogerioD (D)Common Stock19,225USD 85.00USD 1,634,125SEC 申报 ↗
2026-09-01Struthers Richard ScottD (D)Common Stock1,069,611USD 85.00USD 90,916,935SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-01WIERENGA WENDELLD (D)Common Stock122,071USD 85.00USD 10,376,035SEC 申报 ↗
2026-09-01Vivaldi Coelho RogerioD (D)Common Stock19,225USD 85.00USD 1,634,125SEC 申报 ↗
2026-09-01Struthers Richard ScottD (D)Common Stock1,069,611USD 85.00USD 90,916,935SEC 申报 ↗
2026-09-01Schilke TobinD (D)Common Stock79,427USD 85.00USD 6,751,295SEC 申报 ↗
2026-09-01Okey StephanieD (D)Common Stock12,325USD 85.00USD 1,047,625SEC 申报 ↗
2026-09-01Nichols WestonD (D)Common Stock22,225USD 85.00USD 1,889,125SEC 申报 ↗
2026-09-01Kalofonos IsabelD (D)Common Stock35,669USD 85.00USD 3,031,865SEC 申报 ↗
2026-09-01Fust Matthew KD (D)Common Stock28,761USD 85.00USD 2,444,685SEC 申报 ↗
2026-09-01Deardorf CarenD (D)Common Stock22,225USD 85.00USD 1,889,125SEC 申报 ↗
2026-09-01Betz Stephen F.D (D)Common Stock137,936USD 85.00USD 11,724,560SEC 申报 ↗
2026-09-01Bedrosian Camille LD (D)Common Stock22,225USD 85.00USD 1,889,125SEC 申报 ↗
2026-08-20Schilke Tobin奖励／授予 (A)Common Stock471USD 0.00USD 0SEC 申报 ↗
2026-08-07Struthers Richard Scott期权行权／转换 (M)Common Stock19,928USD 20.07USD 399,988SEC 申报 ↗
2026-07-02Vivaldi Coelho Rogerio卖出 (S)Common Stock3,000USD 40.00USD 120,000SEC 申报 ↗
2026-06-18WIERENGA WENDELL奖励／授予 (A)Common Stock5,925USD 0.00USD 0SEC 申报 ↗
2026-06-18Vivaldi Coelho Rogerio奖励／授予 (A)Common Stock5,925USD 0.00USD 0SEC 申报 ↗
2026-06-18Okey Stephanie奖励／授予 (A)Common Stock5,925USD 0.00USD 0SEC 申报 ↗
2026-06-18Nichols Weston奖励／授予 (A)Common Stock5,925USD 0.00USD 0SEC 申报 ↗
2026-06-18Fust Matthew K奖励／授予 (A)Common Stock5,925USD 0.00USD 0SEC 申报 ↗
2026-06-18Deardorf Caren奖励／授予 (A)Common Stock5,925USD 0.00USD 0SEC 申报 ↗
2026-06-18Bedrosian Camille L奖励／授予 (A)Common Stock5,925USD 0.00USD 0SEC 申报 ↗
2026-06-17Okey Stephanie卖出 (S)Common Stock6,900USD 35.67USD 246,143SEC 申报 ↗
2026-05-29Struthers Richard Scott赠与 (G)Common Stock413,300USD 0.00USD 0SEC 申报 ↗
2026-04-08Knight Jeff E.卖出 (S)Common Stock85,163USD 40.10USD 3,415,036SEC 申报 ↗
2026-04-08Knight Jeff E.期权行权／转换 (M)Common Stock78,434USD 22.42USD 1,758,818SEC 申报 ↗
2026-03-16Struthers Richard Scott卖出 (S)Common Stock21,981USD 37.37USD 821,513SEC 申报 ↗
2026-03-16Knight Jeff E.卖出 (S)Common Stock9,911USD 37.37USD 370,411SEC 申报 ↗
2026-03-16Betz Stephen F.卖出 (S)Common Stock10,612USD 37.37USD 396,610SEC 申报 ↗
2026-03-12Vivaldi Coelho Rogerio卖出 (S)Common Stock5,000USD 36.15USD 180,761SEC 申报 ↗
2026-03-03Schilke Tobin卖出 (S)Common Stock6,713USD 39.67USD 266,305SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码CRNX
CIK0001658247
行业Healthcare
细分行业— Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所—

数据覆盖

本地 Form 4 历史372 transaction lines from 2020-01-29 to 2026-09-01
7 P purchase lines · 171 S sale lines · 194 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.